BlackRock, Inc. 13D and 13G filings for Edwards Lifesciences Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-25 1:48 pm Sale |
2023-12-31 | 13G | Edwards Lifesciences Corporation EW |
BlackRock Inc. BLK |
52,171,889 8.600% |
-888,619 (-1.67%) |
Filing |
| 2023-02-07 2:10 pm Sale |
2022-12-31 | 13G | Edwards Lifesciences Corporation EW |
BlackRock Inc. BLK |
53,060,508 8.600% |
-3,980,475 (-6.98%) |
Filing |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | Edwards Lifesciences Corporation EW |
BlackRock Inc. BLK |
57,040,983 9.100% |
-1,555,577 (-2.65%) |
Filing |
| 2021-01-29 09:56 am Purchase |
2020-12-31 | 13G | Edwards Lifesciences Corporation EW |
BlackRock Inc. BLK |
58,596,560 9.400% |
3,994,163 (+7.31%) |
Filing |